{"transactions":[{"id":309434,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-19T20:05:02.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":33,"price":453.45,"value":14963.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025."}],"balance_after":7284,"source":{"system":"sec-edgar","filing":"0000875320-26-000226","document":"wk-form4_1779221100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000226/wk-form4_1779221100.xml","form_type":"4"}},{"id":312732,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T23:06:58.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":620,"price":486.35,"value":301537.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025."}],"balance_after":7284,"source":{"system":"sec-edgar","filing":"0000875320-26-000112","document":"wk-form4_1772147216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000112/wk-form4_1772147216.xml","form_type":"4"}},{"id":312731,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T23:06:58.000Z","date":"2026-02-24","kind":"tax_withholding","planned":true,"acquired":false,"shares":582,"price":485.11,"value":282334.02,"ownership":{"direct":true},"balance_after":7904,"source":{"system":"sec-edgar","filing":"0000875320-26-000112","document":"wk-form4_1772147216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000112/wk-form4_1772147216.xml","form_type":"4"}},{"id":313143,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-19T21:12:47.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":1182,"price":473.68,"value":559889.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025."}],"balance_after":8486,"source":{"system":"sec-edgar","filing":"0000875320-26-000088","document":"wk-form4_1771535561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000088/wk-form4_1771535561.xml","form_type":"4"}},{"id":313142,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-19T21:12:47.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":2437,"price":489.46,"value":1192814.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025."}],"balance_after":9668,"source":{"system":"sec-edgar","filing":"0000875320-26-000088","document":"wk-form4_1771535561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000088/wk-form4_1771535561.xml","form_type":"4"}},{"id":313141,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-19T21:12:47.000Z","date":"2026-02-17","kind":"tax_withholding","planned":true,"acquired":false,"shares":1110,"price":483.75,"value":536962.5,"ownership":{"direct":true},"balance_after":12105,"source":{"system":"sec-edgar","filing":"0000875320-26-000088","document":"wk-form4_1771535561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000088/wk-form4_1771535561.xml","form_type":"4"}},{"id":313140,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-19T21:12:47.000Z","date":"2026-02-17","kind":"grant","planned":true,"acquired":true,"shares":2584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in installments beginning on February 20, 2027."}],"balance_after":13215,"source":{"system":"sec-edgar","filing":"0000875320-26-000088","document":"wk-form4_1771535561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000088/wk-form4_1771535561.xml","form_type":"4"}},{"id":313476,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-18T21:32:23.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2283,"price":487.76,"value":1113556.08,"ownership":{"direct":true},"balance_after":10631,"source":{"system":"sec-edgar","filing":"0000875320-26-000068","document":"wk-form4_1771450339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000068/wk-form4_1771450339.xml","form_type":"4"}},{"id":313864,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:56:10.000Z","date":"2026-02-11","kind":"sale","planned":true,"acquired":false,"shares":2021,"price":460.43,"value":930529.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025."}],"balance_after":12914,"source":{"system":"sec-edgar","filing":"0000875320-26-000044","document":"wk-form4_1770933367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000044/wk-form4_1770933367.xml","form_type":"4"}},{"id":313863,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14631,"kind":"person","name":"Bunnage Mark E.","position":1,"cik":"0002100735","reported_name":"Bunnage Mark E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:56:10.000Z","date":"2026-02-10","kind":"tax_withholding","planned":true,"acquired":false,"shares":1127,"price":468.41,"value":527898.07,"ownership":{"direct":true},"balance_after":14935,"source":{"system":"sec-edgar","filing":"0000875320-26-000044","document":"wk-form4_1770933367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000044/wk-form4_1770933367.xml","form_type":"4"}}]}